Syros to Present New Preclinical Data on SY-5609 at ASCO Virtual Scientific Program
These data will be presented at the 2020 American Society of Clinical Oncology Virtual Scientific Program (ASCO20) taking place May 29-31.
- These data will be presented at the 2020 American Society of Clinical Oncology Virtual Scientific Program (ASCO20) taking place May 29-31.
- Syros will also present on the design of its ongoing Phase 1 trial of SY-5609 at ASCO20.
- Syros is redefining the power of small molecules to control the expression of genes.
- Syros also has multiple preclinical and discovery programs in oncology and monogenic diseases.